Editorial: Exploiting Novel Combined Host- and Pathogen-Directed Therapies for Combating Bacterial Multidrug Resistance

Front Immunol. 2020 Nov 4:11:616486. doi: 10.3389/fimmu.2020.616486. eCollection 2020.

Authors

Roberto Nisini¹, Marco R Oggioni^{2

3}, Gian Maria Rossolini⁴, Maurizio Fraziano⁵

Affiliations

¹ Department of Infectious Diseases, Istituto Superiore di Sanità, Roma, Italy.
² Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom.
³ Dipartimento di Farmacia e Biotecnologie, Università di Bologna, Bologna, Italy.
⁴ Clinical Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy.
⁵ Department of Biology, University of Rome Tor Vergata, Rome, Italy.

No abstract available

Keywords: bacteria; host-directed therapy; innate immunity; multidrug resistance; pathogen-directed therapy.

Publication types

Editorial
Introductory Journal Article
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Anti-Bacterial Agents / pharmacology*
Bacterial Infections / microbiology
Drug Resistance, Multiple, Bacterial / drug effects*
Host-Pathogen Interactions / drug effects*
Humans

Substances

Anti-Bacterial Agents